Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma of Lung

Clinical trial condition

Adenocarcinoma of Lung

Explore clinical trials studying Adenocarcinoma of Lung. Study availability and eligibility vary by location and protocol.

266 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma of Lung trial results

Completed

Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00006484

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: MBCCOP - Gulf Coast Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States

View all 93 locations

View Trial Details

Completed

Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

NCT00005630

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00040794

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +20 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00118183

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +24 more
Locations: Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States

View Trial Details

Completed

Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer

NCT00601796

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer

NCT00077415

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations: Sydney Cancer Centre at Royal Prince Alfred Hospital Sydney, New South Wales, Australia

Sir Charles Gairdner Hospital - Perth Perth, Western Australia, Australia

Prince of Wales Hospital Shatin, New Territories, Hong Kong

Cancer Institute at National University Hospital Singapore

View Trial Details

Completed

Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00411047

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00293280

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00425646

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations: Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

NCT00002823

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: Comprehensive Cancer Center at JFK Medical Center Atlantis, Florida, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Getlac Buenos Aires, Argentina

South Eastern Sydney Area Health Service Randwick, New South Wales, Australia

View all 123 locations

View Trial Details